Search research articles
Contact Us
Filters
Showing results (241-250 of 520) with videos related to
Page
of 52
Sort By:
Diabetes Care
|
July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study
Hertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
Journal of the American College of Cardiology
|
February 19, 2013
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease
Torbjørn Omland, Marc A Pfeffer, Scott D Solomon, et al.
Journal of the American College of Cardiology
|
July 17, 2007
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial
Torbjørn Omland, Marc S Sabatine, Kathleen A Jablonski, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
October 6, 2021
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF
Thor Ueland, Lars Gullestad, Lei Kou, et al.
The New England Journal of Medicine
|
April 27, 2017
Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation
Simon de Denus, Eileen O'Meara, Akshay S Desai, et al.
European Journal of Heart Failure
|
May 23, 2026
Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trial
Jacinthe Boulet, Jean-Lucien Rouleau, Mark Petrie, et al.
European Journal of Heart Failure
|
January 26, 2022
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF
Maria A Pabón, Jonathan W Cunningham, Brian L Claggett, et al.
European Heart Journal
|
October 27, 2009
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial
Jonathan P Piccini, Min Zhang, Karen Pieper, et al.
Circulation. Heart Failure
|
March 26, 2013
Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy
Patricia Campbell, Madoka Takeuchi, Mikhail Bourgoun, et al.
American Heart Journal
|
April 29, 2006
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial
John J V McMurray, James B Young, Mark E Dunlap, et al.
Page
of 52
Search research articles
Search
Showing results (241-250 of 520) with videos related to
Sort By:
Page
of 52
Diabetes Care
|
July 11, 2022
Protein Biomarkers and Cardiovascular Outcomes in People With Type 2 Diabetes and Acute Coronary Syndrome: The ELIXA Biomarker Study
Hertzel C Gerstein, Sibylle Hess, Brian Claggett, et al.
Journal of the American College of Cardiology
|
February 19, 2013
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease
Torbjørn Omland, Marc A Pfeffer, Scott D Solomon, et al.
Journal of the American College of Cardiology
|
July 17, 2007
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial
Torbjørn Omland, Marc S Sabatine, Kathleen A Jablonski, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
October 6, 2021
Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF
Thor Ueland, Lars Gullestad, Lei Kou, et al.
The New England Journal of Medicine
|
April 27, 2017
Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation
Simon de Denus, Eileen O'Meara, Akshay S Desai, et al.
European Journal of Heart Failure
|
May 23, 2026
Cardiovascular events after acute myocardial infarction complicated by low ejection fraction and/or congestion: a landmark analysis of the PARADISE-MI trial
Jacinthe Boulet, Jean-Lucien Rouleau, Mark Petrie, et al.
European Journal of Heart Failure
|
January 26, 2022
Natriuretic peptide-based inclusion criteria in heart failure with preserved ejection fraction clinical trials: insights from PARAGON-HF
Maria A Pabón, Jonathan W Cunningham, Brian L Claggett, et al.
European Heart Journal
|
October 27, 2009
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial
Jonathan P Piccini, Min Zhang, Karen Pieper, et al.
Circulation. Heart Failure
|
March 26, 2013
Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy
Patricia Campbell, Madoka Takeuchi, Mikhail Bourgoun, et al.
American Heart Journal
|
April 29, 2006
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial
John J V McMurray, James B Young, Mark E Dunlap, et al.
Page
of 52